Stay updated on Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer
Sign up to get notified when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.

Latest updates to the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision, v3.3.2, has been added to the study's history, and the previous revision v3.2.0 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedThe funding/operating status notice banner at the top of the page has been removed. The change affects only presentation and does not alter the trial data or status.SummaryDifference0.8%

- Check34 days agoChange DetectedRecord History shows a new version entry with updated status and dates, reflecting routine updates to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedUpdated operating status notice and new version (v3.2.0), replacing the previous v3.1.0. The page now provides current guidance on NIH Clinical Center operations and references official status sources.SummaryDifference13%

- Check69 days agoChange DetectedThe page now lists revision v3.1.0 as the current version, replacing v3.0.2.SummaryDifference0.3%

- Check84 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2 and the 'Back to Top' control was removed. No changes to core content, pricing, stock availability, or time-slot availability.SummaryDifference0.8%

Stay in the know with updates to Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.